Literature DB >> 3499870

Reduction of the number of immunocompetent cells in the acute stage of herpes zoster.

O Baadsgaard1, R Lindskov, C Geisler.   

Abstract

Circulating and in situ mononuclear cell subsets were phenotypically characterized during both the acute and convalescent phase of herpes zoster infections in 14 patients. In peripheral blood a significant reduction in the absolute number of Leu 4+ T cells, Leu 2a+ suppressor/cytotoxic T cells, Leu 3a+ helper/inducer T cells, Leu 7+ killer cells, and B1+ B cells were found during the acute stage compared to convalescents and normal controls. In contrast no change in the absolute number of MO2+ monocytes was seen in the acute stage of the disease. During convalescence a return to normal values in the lymphocyte subsets and killer cells was seen within 1-2 months after the initial disease presentation. In skin biopsy specimens from 4 of the 14 patients with active herpes zoster lesions the cellular infiltrate consisted of T cells (Leu 4+) the majority being helper/inducer T cells (Leu 3a+). Most of the cells expressed HLA-DR (Ia) antigens and were according to this in an activated state. The observed changes in effector and regulatory cell numbers may have implications for the acquisition of Varicella-zoster virus infections, the immune deficiency state associated with the disease, and/or the immune response to resolve the infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499870     DOI: 10.1007/BF00412622

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  8 in total

1.  Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.

Authors:  T Iwasaka; J F Sheridan; L Aurelian
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

2.  Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus.

Authors:  A A Nash; P G Gell
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

3.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

4.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

5.  Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.

Authors:  O S Sørensen; S Haahr; A Møller-Larsen; K Wildenhoff
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

6.  Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis.

Authors:  D H Crawford; P Brickell; N Tidman; I McConnell; A V Hoffbrand; G Janossy
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

7.  Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression.

Authors:  M A Vadas; J F Miller; I F McKenzie; S E Chism; F W Shen; E A Boyse; J R Gamble; A M Whitelaw
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

8.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

  8 in total
  2 in total

Review 1.  Neurologic manifestations of varicella zoster virus infections.

Authors:  Catherine Amlie-Lefond; Burk Jubelt
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 6.030

Review 2.  Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults.

Authors:  James C Barton; J Clayborn Barton; Luigi F Bertoli
Journal:  Infect Dis Rep       Date:  2012-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.